Their mission is to identify innovative research in life science and to develop novel therapies and tools by creating successful business initiatives in a sustained and long term way. Genextra's holding structure is designed to increase the probability of success of business initiatives that become part of the Group by providing specialist management as well as financial support to a new company vehicle or an existing young start-up. Genextra was created in 2004 by a group of prominent Italian entrepreneurs and financial institutions in partnership with leading scientists from the European Institute of Oncology (IEO). To date, Genextra has raised over €116 million and represents one of very few examples in Italy of private capital invested for the benefit of research and innovation.
Focus Areas
Investment Types
Notable Investments
